These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9403281)

  • 1. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis.
    Lorenzen JM; Broll M; Kaever V; Burhenne H; Hafer C; Clajus C; Knitsch W; Burkhardt O; Kielstein JT
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):385-90. PubMed ID: 22223613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of ampicillin/sulbactam (2:1) combination after intravenous administration to sheep and goats.
    Carceles CM; Espuny A; Vicente MS; Diaz MS; Escudero E
    Res Vet Sci; 1996 Sep; 61(2):143-6. PubMed ID: 8880984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
    Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
    Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function.
    Brogard JM; Comte F; Spach MO; Lavillaureix J
    Chemotherapy; 1982; 28(5):318-26. PubMed ID: 6216076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
    Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
    Blum RA; Kohli RK; Harrison NJ; Schentag JJ
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of an ampicillin/sulbactam combination administered intramuscularly in lactating sheep and goats.
    Escudero E; Espuny A; Vicente MS; Cárceles CM
    Vet Res; 1996; 27(3):201-8. PubMed ID: 8767882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.
    Martin C; Cotin A; Giraud A; Beccani-Argème M; Alliot P; Mallet MN; Argème M
    Antimicrob Agents Chemother; 1998 May; 42(5):1093-7. PubMed ID: 9593133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.
    Wolter K; Claus M; Wagner K; Fritschka E
    Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD.
    Khadzhynov D; Slowinski T; Lieker I; Spies C; Puhlmann B; König T; Uhrig A; Eggers K; Neumayer HH; Traunmüller F; Joukhadar C; Peters H
    Int J Clin Pharmacol Ther; 2011 Nov; 49(11):656-65. PubMed ID: 22011690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
    Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R
    J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis.
    Gonwa TA; Mai ML; Melton LB; Hays SR; Goldstein RM; Levy MF; Klintmalm GB
    Transplantation; 2001 May; 71(10):1424-8. PubMed ID: 11391230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.